Abstract
Since the early SARS-CoV-2 pandemic, cancer patients have been assumed to be at higher risk for severe COVID-19. Here, we present an analysis of cancer patients from the LEOSS (Lean European Open Survey on SARS-CoV-2 Infected Patients) registry to determine whether cancer patients are at higher risk.
Beteiligte Forschungseinheiten
Identifier
doi: 10.1007/s00277-020-04328-4
PMID: 33159569